Marieh Esmaeelpour1, Siamak Ansari-Shahrezaei2, Carl Glittenberg2, Susanne Nemetz3, Martin F Kraus4, Joachim Hornegger4, James G Fujimoto5, Wolfgang Drexler6, Susanne Binder2. 1. Ludwig Boltzmann Institute for Retinology and Biomicroscopic Laser Surgery, Department of Ophthalmology, Rudolf Foundation Clinic, Vienna, Austria Center for Medical Physics and Biomedical Engineering, Medical University Vienna, Vienna, Austria. 2. Ludwig Boltzmann Institute for Retinology and Biomicroscopic Laser Surgery, Department of Ophthalmology, Rudolf Foundation Clinic, Vienna, Austria. 3. Optik Nemetz, Vienna, Austria. 4. Pattern Recognition Lab and School of Advanced Optical Technologies, University Erlangen-Nuremberg, Erlangen, Germany. 5. Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States. 6. Center for Medical Physics and Biomedical Engineering, Medical University Vienna, Vienna, Austria.
Abstract
PURPOSE: To analyze choroidal, Sattler's, and Haller's layer thickness maps in age-related macular degeneration (AMD) patients having eyes with bilateral large drusen and pigment changes (intermediate AMD), in patients having intermediate AMD eyes with neovascular fellow eyes (nAMD), and in healthy subjects using three-dimensional (3D) 1060-nm optical coherence tomography (OCT). METHODS: Automatically generated choroidal thickness (ChT), retinal thickness, and Sattler's and Haller's layer thickness maps were statistically analyzed in 67 subjects consisting of intermediate AMD (n = 21), intermediate AMD (n = 22) with fellow nAMD eyes (n = 22), and healthy eyes (n = 24) with no age and axial eye length difference between groups of eyes (P > 0.05, ANOVA). Eyes were imaged by a prototype high-speed (60,000 A-scans/s) spectral-domain 3D 1060-nm OCT over a 36° × 36° field of view. RESULTS: The mean ± SD (μm) subfoveal ChT for healthy subjects and for bilateral intermediate AMD, unilateral intermediate AMD, and their nAMD fellow eyes was 259 ± 95 and 222 ± 98, 149 ± 60, and 171 ± 78, respectively. Choroidal thickness maps demonstrated significant submacular thinning in unilateral intermediate AMD in comparison to healthy and bilateral intermediate AMD eyes (P < 0.001, ANOVA, post hoc P < 0.001 and P < 0.05, respectively). Sattler's and Haller's layers were thinnest in intermediate AMDs that presented with nAMD fellow eyes (Kruskal-Wallis test P < 0.01). For the choroid and its sublayers, there was no difference between the intermediate AMD eyes and their fellow nAMD eyes (paired testing, P < 0.05). CONCLUSIONS: The 3D 1060-nm OCT choroidal imaging visualized significant changes in choroidal, Sattler's, and Haller's layer thickness in relation to the progression of AMD. This may be important for understanding the choroidopathy in the pathophysiology of AMD. Copyright 2014 The Association for Research in Vision and Ophthalmology, Inc.
PURPOSE: To analyze choroidal, Sattler's, and Haller's layer thickness maps in age-related macular degeneration (AMD) patients having eyes with bilateral large drusen and pigment changes (intermediate AMD), in patients having intermediate AMD eyes with neovascular fellow eyes (nAMD), and in healthy subjects using three-dimensional (3D) 1060-nm optical coherence tomography (OCT). METHODS: Automatically generated choroidal thickness (ChT), retinal thickness, and Sattler's and Haller's layer thickness maps were statistically analyzed in 67 subjects consisting of intermediate AMD (n = 21), intermediate AMD (n = 22) with fellow nAMD eyes (n = 22), and healthy eyes (n = 24) with no age and axial eye length difference between groups of eyes (P > 0.05, ANOVA). Eyes were imaged by a prototype high-speed (60,000 A-scans/s) spectral-domain 3D 1060-nm OCT over a 36° × 36° field of view. RESULTS: The mean ± SD (μm) subfoveal ChT for healthy subjects and for bilateral intermediate AMD, unilateral intermediate AMD, and their nAMD fellow eyes was 259 ± 95 and 222 ± 98, 149 ± 60, and 171 ± 78, respectively. Choroidal thickness maps demonstrated significant submacular thinning in unilateral intermediate AMD in comparison to healthy and bilateral intermediate AMD eyes (P < 0.001, ANOVA, post hoc P < 0.001 and P < 0.05, respectively). Sattler's and Haller's layers were thinnest in intermediate AMDs that presented with nAMD fellow eyes (Kruskal-Wallis test P < 0.01). For the choroid and its sublayers, there was no difference between the intermediate AMD eyes and their fellow nAMD eyes (paired testing, P < 0.05). CONCLUSIONS: The 3D 1060-nm OCT choroidal imaging visualized significant changes in choroidal, Sattler's, and Haller's layer thickness in relation to the progression of AMD. This may be important for understanding the choroidopathy in the pathophysiology of AMD. Copyright 2014 The Association for Research in Vision and Ophthalmology, Inc.
Authors: Vedran Kajić; Boris Povazay; Boris Hermann; Bernd Hofer; David Marshall; Paul L Rosin; Wolfgang Drexler Journal: Opt Express Date: 2010-07-05 Impact factor: 3.894
Authors: Christina A Korb; Ulrike B Kottler; Christian Wolfram; René Hoehn; Andreas Schulz; Isabella Zwiener; Philipp S Wild; Norbert Pfeiffer; Alireza Mirshahi Journal: Graefes Arch Clin Exp Ophthalmol Date: 2014-02-25 Impact factor: 3.117
Authors: Helena Buch; Niels V Nielsen; Troels Vinding; Gorm B Jensen; Jan U Prause; Morten la Cour Journal: Ophthalmology Date: 2005-05 Impact factor: 12.079
Authors: Elliott H Sohn; Aditi Khanna; Budd A Tucker; Michael D Abràmoff; Edwin M Stone; Robert F Mullins Journal: Invest Ophthalmol Vis Sci Date: 2014-03-06 Impact factor: 4.799
Authors: Dawn A Sim; Pearse A Keane; Hemal Mehta; Simon Fung; Javier Zarranz-Ventura; Marcus Fruttiger; Praveen J Patel; Catherine A Egan; Adnan Tufail Journal: Invest Ophthalmol Vis Sci Date: 2013-04-23 Impact factor: 4.799
Authors: Giulio Barteselli; Dirk-Uwe Bartsch; Robert N Weinreb; Natalia Camacho; Joseph T Nezgoda; Amir H Marvasti; William R Freeman Journal: Retina Date: 2016-06 Impact factor: 4.256
Authors: Fang Zheng; Giovanni Gregori; Karen B Schaal; Andrew D Legarreta; Andrew R Miller; Luiz Roisman; William J Feuer; Philip J Rosenfeld Journal: Invest Ophthalmol Vis Sci Date: 2016-11-01 Impact factor: 4.799